| Code | 66015 | ||||||||||
| MA number | 83/0329/91-CS | ||||||||||
| Product Form: | tbl plg 100x100 mg (fľ.PE) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | National | ||||||||||
| MAH, country: | STADA Arzneimittel AG, Germany | ||||||||||
| Therapeutic Class: | 83 - VASODILATANTIA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10a well-established use application |
| MA issued: | 03.12.1991 |
| Pediatric posology: | Yes |
| SPC: |
SPC_ENELBIN 100 retard_tbl plg_05_2021.pdf
|
| PIL: |
PIL_ENELBIN 100 retard_tbl plg_05_2021.pdf
|
| Safety feature | Yes |
| Data update: | 16.05.2018 |
